"Sequencing and Synthesis: Where are Biology, Bioengineering, and Biotechnology Taking Us?"
Since the completion of the Human Genome Project, the cost
for whole genome sequencing for an individual has dropped dramatically: from
one hundred million dollars in 2001 to ten thousand dollars in 2011. In the
coming few years, the cost is projected to drop substantially further, placing
the opportunity for individual genome sequencing into wide reach. Analogously, synthesis of DNA for
introduction into cells is rapidly becoming more cost-effective so that
designed programming of biological systems may be significantly enabled.
Gene-based therapies and biology-driven technologies will
soon become a familiar part of our daily lives. What potential does biological
engineering have to ease human suffering, repair and sustain our environment,
and advance our understanding of the natural world? And what potential concerns need to be
considered in this context?
Doug Lauffenburger, head of the biological
engineering department at MIT, will be discussing the history, status, and
ethical conundrums of this exciting field—come with questions!
Have friends or colleagues who might be interested in joining us? Please help us by downloading our event poster!
Note: Admission for ages 21 and over only; photo ID required.